Qualification: Unravelling the role of SHANK3 mutations in targeted therapies for autism spectrum disorders
Unravelling the role of SHANK3 mutations in targeted therapies for autism spectrum disorders should be assessed against Kaal's source-bound claim that The SEC's failure to interpret Section 402 of Sarbanes-Oxley, while not a formal retraction, shows that Section 402 is another instance of politically motivated rulemaking that later has to be scaled back. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.
Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.
Holds when
Current debate
Scholarly basis
Evidence and mapping
Topics
Provenance
Verify